Artra Group Past Earnings Performance
Past criteria checks 3/6
Artra Group has been growing earnings at an average annual rate of 21.5%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 14.2% per year. Artra Group's return on equity is 4.4%, and it has net margins of 1.4%.
Key information
21.5%
Earnings growth rate
22.5%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 14.2% |
| Return on equity | 4.4% |
| Net Margin | 1.4% |
| Next Earnings Update | 13 Nov 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Artra Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4,440 | 61 | 1,342 | 0 |
| 31 Mar 24 | 4,519 | 88 | 1,356 | 0 |
| 31 Dec 23 | 4,497 | 53 | 1,384 | 0 |
| 30 Sep 23 | 4,429 | -71 | 1,437 | 0 |
| 30 Jun 23 | 4,610 | -44 | 1,495 | 0 |
| 31 Mar 23 | 4,601 | -35 | 1,506 | 0 |
| 31 Dec 22 | 4,671 | 2 | 1,536 | 0 |
| 30 Sep 22 | 4,520 | -236 | 1,503 | 0 |
| 30 Jun 22 | 3,987 | -364 | 1,358 | 0 |
| 31 Mar 22 | 3,645 | -352 | 1,222 | 0 |
| 31 Dec 21 | 3,158 | -351 | 1,060 | 0 |
| 30 Sep 21 | 2,666 | -500 | 904 | 0 |
| 30 Jun 21 | 2,580 | -355 | 859 | 0 |
| 31 Mar 21 | 2,446 | -432 | 842 | 0 |
| 31 Dec 20 | 2,426 | -440 | 859 | 0 |
| 30 Sep 20 | 2,456 | -190 | 873 | 0 |
| 30 Jun 20 | 2,552 | -242 | 884 | 0 |
| 31 Mar 20 | 2,688 | -192 | 914 | 0 |
| 31 Dec 19 | 2,833 | -146 | 886 | 0 |
| 30 Sep 19 | 2,969 | -211 | 861 | 0 |
| 30 Jun 19 | 3,026 | 131 | 898 | 0 |
| 31 Mar 19 | 3,281 | 205 | 917 | 0 |
| 31 Dec 18 | 3,479 | 269 | 957 | 0 |
Quality Earnings: 6029 has high quality earnings.
Growing Profit Margin: 6029 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6029 has become profitable over the past 5 years, growing earnings by 21.5% per year.
Accelerating Growth: 6029 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 6029 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (9.6%).
Return on Equity
High ROE: 6029's Return on Equity (4.4%) is considered low.